{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:51:56Z","timestamp":1770479516191,"version":"3.49.0"},"reference-count":49,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"DOI":"10.1210\/jc.2008-2156","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T01:45:39Z","timestamp":1232588739000},"page":"1229-1235","source":"Crossref","is-referenced-by-count":38,"title":["Retinol-Binding Protein 4 in Polycystic Ovary Syndrome\u2014Association with Steroid Hormones and Response to Pioglitazone Treatment"],"prefix":"10.1210","volume":"94","author":[{"given":"Elmar","family":"Aigner","sequence":"first","affiliation":[{"name":"Department of Internal Medicine (E.A., F.H., C.D.), General Hospital Oberndorf, 5110 Oberndorf, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Bachofner","sequence":"additional","affiliation":[{"name":"Gynecology and Obstetrics (N.B.), Paracelsus Medical University Salzburg, 5020 Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Klein","sequence":"additional","affiliation":[{"name":"Departments of Laboratory Medicine (K.K., W.P.), Paracelsus Medical University Salzburg, 5020 Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"De Geyter","sequence":"additional","affiliation":[{"name":"Division of Gynecological Endocrinology and Reproductive Medicine (C.D.G.), Women\u2019s Hospital, University of Basel, CH-4031 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Hohla","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (E.A., F.H., C.D.), General Hospital Oberndorf, 5110 Oberndorf, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Patsch","sequence":"additional","affiliation":[{"name":"Departments of Laboratory Medicine (K.K., W.P.), Paracelsus Medical University Salzburg, 5020 Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Datz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (E.A., F.H., C.D.), General Hospital Oberndorf, 5110 Oberndorf, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113321893400_R1","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1471-0528.2006.00990.x","article-title":"The impact of obesity on reproduction in women with polycystic ovary syndrome.","volume":"113","author":"Pasquali","year":"2006","journal-title":"BJOG"},{"issue":"Suppl 1","key":"key\n\t\t\t\t2019041113321893400_R2","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.fertnstert.2006.04.013","article-title":"Metabolic syndrome in women with polycystic ovary syndrome","volume":"86","author":"Essah","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113321893400_R3","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R4","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/0003-4819-132-12-200006200-00010","article-title":"The importance of diagnosing the polycystic ovary syndrome.","volume":"132","author":"Lobo","year":"2000","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113321893400_R5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/ncpendmet0637","article-title":"The reproductive phenotype in polycystic ovary syndrome.","volume":"3","author":"Chang","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/GRF.0b013e31802f3547","article-title":"The metabolic syndrome in polycystic ovary syndrome.","volume":"50","author":"Essah","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041113321893400_R7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2337\/db07-0932","article-title":"High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype.","volume":"57","author":"Taksali","year":"2008","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113321893400_R8","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1210\/jc.2007-2521","article-title":"Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy.","volume":"93","author":"Vantyghem","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ncpendmet0755","article-title":"Cardiometabolic features of polycystic ovary syndrome.","volume":"4","author":"Hoffman","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R10","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome.","volume":"88","author":"Christian","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1530\/eje.1.02156","article-title":"Insulin-sensitizing agents in polycystic ovary syndrome.","volume":"154","author":"Pasquali","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113321893400_R12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0889-8545(05)70191-1","article-title":"Insulin-lowering drugs in polycystic ovary syndrome.","volume":"28","author":"Iuorno","year":"2001","journal-title":"Obstet Gynecol Clin North Am"},{"key":"key\n\t\t\t\t2019041113321893400_R13","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials.","volume":"93","author":"Hoeger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R14","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome.","volume":"338","author":"Nestler","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113321893400_R15","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2003-031737","article-title":"Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome.","volume":"89","author":"Brettenthaler","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R16","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.","volume":"90","author":"Ortega-Gonzalez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1517\/14656566.9.7.1087","article-title":"Pleiotropic effects of thiazolidinediones.","volume":"9","author":"Rizos","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t2019041113321893400_R18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11906-008-0029-7","article-title":"The link between abdominal obesity and the metabolic syndrome.","volume":"10","author":"Phillips","year":"2008","journal-title":"Curr Hypertens Rep"},{"key":"key\n\t\t\t\t2019041113321893400_R19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/157339906775473617","article-title":"The new adipose tissue and adipocytokines.","volume":"2","author":"Bulcao","year":"2006","journal-title":"Curr Diabetes Rev"},{"key":"key\n\t\t\t\t2019041113321893400_R20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.diabet.2007.09.004","article-title":"Adipokines: the missing link between insulin resistance and obesity.","volume":"34","author":"Antuna-Puente","year":"2008","journal-title":"Diabetes Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R21","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.","volume":"354","author":"Graham","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113321893400_R22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/eje.1.02024","article-title":"Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome.","volume":"153","author":"Hahn","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113321893400_R23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity.","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t2019041113321893400_R24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2265.2007.03145.x","article-title":"The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.","volume":"69","author":"Amato","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113321893400_R25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.numecd.2008.05.004","article-title":"Insulin resistance and polycystic ovary syndrome.","volume":"18","author":"Galluzzo","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"key\n\t\t\t\t2019041113321893400_R26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.gco.0000193004.35287.89","article-title":"The role of the leptin in reproduction.","volume":"18","author":"Cervero","year":"2006","journal-title":"Curr Opin Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041113321893400_R27","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1210\/jc.2002-022033","article-title":"Adiponectin levels in women with polycystic ovary syndrome.","volume":"88","author":"Orio Jr","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R28","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1210\/jc.2003-030219","article-title":"Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.","volume":"88","author":"Ducluzeau","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/BF03347474","article-title":"Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.","volume":"27","author":"Sieminska","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113321893400_R30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2265.2004.02159.x","article-title":"Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.","volume":"61","author":"Spranger","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113321893400_R31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/09513590600917943","article-title":"Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome.","volume":"22","author":"Gulcelik","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t2019041113321893400_R32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/eje.1.02207","article-title":"Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.","volume":"155","author":"Glintborg","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113321893400_R33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/CS20070196","article-title":"Role of adiponectin and PBEF\/visfatin as regulators of inflammation: involvement in obesity-associated diseases.","volume":"114","author":"Tilg","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"key\n\t\t\t\t2019041113321893400_R34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2265.2007.03015.x","article-title":"Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome.","volume":"68","author":"Glintborg","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113321893400_R35","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/humrep\/deg264","article-title":"Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.","volume":"18","author":"Romualdi","year":"2003","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113321893400_R36","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113321893400_R37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0015-0282(98)00454-3","article-title":"Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.","volume":"71","author":"Hasegawa","year":"1999","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113321893400_R38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1530\/eje.0.1440509","article-title":"Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome.","volume":"144","author":"Kowalska","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113321893400_R39","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0015-0282(16)57804-2","article-title":"Modulation of anterior pituitary luteinizing hormone response to gonadotropin-releasing hormone by insulin-like growth factor I in vitro.","volume":"64","author":"Soldani","year":"1995","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113321893400_R40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1530\/eje.0.1310641","article-title":"Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro.","volume":"131","author":"Soldani","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113321893400_R41","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/humrep\/dem118","article-title":"Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.","volume":"22","author":"Kowalska","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041113321893400_R42","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1210\/jc.2006-0936","article-title":"Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.","volume":"91","author":"Tan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/EJE-07-0833","article-title":"Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome.","volume":"158","author":"Mohlig","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113321893400_R44","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2337\/dc07-2265","article-title":"Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome.","volume":"31","author":"Hutchison","year":"2008","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113321893400_R45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1530\/EJE-07-0143","article-title":"Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.","volume":"157","author":"Hahn","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113321893400_R46","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1210\/jc.2007-0091","article-title":"Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids.","volume":"92","author":"Tan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R47","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1210\/jc.2005-0469","article-title":"Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production.","volume":"90","author":"Seto-Young","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R48","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1210\/jc.2006-1935","article-title":"Interactions among peroxisome proliferator activated receptor-\u03b3, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells.","volume":"92","author":"Seto-Young","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113321893400_R49","article-title":"Thiazolidinediones inhibit estrogen synthesis by interfering with androgen binding to aromatase","author":"Avtanski DB"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/4\/1229\/10806717\/jcem1229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T09:50:17Z","timestamp":1709977817000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/4\/1229\/2596322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-2156","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}